{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:14:05Z","timestamp":1792037645209,"version":"4.4.0"},"reference-count":22,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>In recurrent atypical meningioma, the survival impact of volumetric extent of resection (vEOR) and residual tumor volume (RTV) has not been previously studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors performed a retrospective vEOR analysis of patients with recurrent World Health Organization grade II meningiomas treated with reresection from 2000 to 2019. The Kaplan-Meier method and multivariate Cox regression analysis were used to study progression-free survival (PFS) and overall survival (OS).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Fifty-nine patients with a median follow-up duration of 95 (95% CI 42\u2013148) months were included. The median (range) vEOR was 100% (32%\u2013100%) and the mean \u00b1 SD was 90.7% \u00b1 15.3%. Among patients who underwent gross-total resection (GTR) (n = 32 [54%]), Simpson grade I and II resections were achieved in 23 (72%) and 9 (28%) patients, respectively. Among patients who underwent subtotal resection (n = 27 [46%]), the median (range) RTV was 4.3 (0.3\u201340) cm<jats:sup>3<\/jats:sup>. The 1-, 2-, and 5-year actuarial PFS rates for the cohort were 76%, 56%, and 34%, respectively. The 1-, 2-, and 5-year actuarial OS rates for the cohort were 98%, 78%, and 60%, respectively. Variables reflecting EOR significantly impacted both PFS and OS in multivariate analysis: GTR (p &lt; 0.01) was significantly associated with longer PFS, and lower Simpson grade (p = 0.04) was significantly associated with longer OS. Additional factors including RTV, Ki-67 index, and pretreatment and posttreatment history also impacted survival outcomes (p &lt; 0.05).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>EOR and Simpson grade were independently associated with survival outcomes in patients with recurrent atypical meningioma. These findings support the practice of thorough reresection for maximal cytoreduction in appropriate surgical candidates.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2022.12.jns221815","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T15:39:31Z","timestamp":1674833971000},"page":"769-779","source":"Crossref","is-referenced-by-count":7,"title":["Volumetric extent of resection and survival for recurrent atypical meningioma"],"prefix":"10.3171","volume":"139","author":[{"given":"Colin J.","family":"Przybylowski","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Phoenix, Arizona; and"},{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Suki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan M.","family":"Raza","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"DeMonte","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"2","key":"b1","series-title":"J Neurosurg","first-page":"475","article-title":"The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection","volume":"119","author":"Hardesty DA","year":"2013","unstructured":"Hardesty DA, Wolf AB, Brachman DG,  The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg. 2013;119(2):475\u2013481."},{"issue":"5","key":"b2","series-title":"J Neurosurg","first-page":"1240","article-title":"Prognostic factors for progression in atypical meningioma","volume":"129","author":"Shakir SI","year":"2018","unstructured":"Shakir SI, Souhami L, Petrecca K,  Prognostic factors for progression in atypical meningioma. J Neurosurg. 2018;129(5):1240\u20131248."},{"issue":"2","key":"b3","series-title":"J Neurooncol","first-page":"173","article-title":"Extent of resection and survival outcomes in World Health Organization grade II meningiomas","volume":"151","author":"Soni P","year":"2021","unstructured":"Soni P, Davison MA, Shao J,  Extent of resection and survival outcomes in World Health Organization grade II meningiomas. J Neurooncol. 2021;151(2):173\u2013179."},{"issue":"24","key":"b4","series-title":"Cancer","first-page":"4376","article-title":"Extent of resection and overall survival for patients with atypical and malignant meningioma","volume":"121","author":"Aizer AA","year":"2015","unstructured":"Aizer AA, Bi WL, Kandola MS,  Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015;121(24):4376\u20134381."},{"issue":"1","key":"b5","series-title":"Neurosurgery","first-page":"56","article-title":"Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation","volume":"64","author":"Aghi MK","year":"2009","unstructured":"Aghi MK, Carter BS, Cosgrove GR,  Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009;64(1):56\u201360."},{"issue":"11","key":"b6","series-title":"Neuro Oncol","first-page":"1547","article-title":"Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma","volume":"16","author":"Aizer AA","year":"2014","unstructured":"Aizer AA, Arvold ND, Catalano P,  Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014;16(11):1547\u20131553."},{"issue":"4","key":"b7","series-title":"J Neurosurg","first-page":"679","article-title":"The role of radiotherapy following gross-total resection of atypical meningiomas","volume":"117","author":"Komotar RJ","year":"2012","unstructured":"Komotar RJ, Iorgulescu JB, Raper DM,  The role of radiotherapy following gross-total resection of atypical meningiomas. J Neurosurg. 2012;117(4):679\u2013686."},{"issue":"1","key":"b8","series-title":"J Neurosurg","first-page":"4","article-title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","volume":"122","author":"Rogers L","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M,  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122(1):4\u201323."},{"issue":"1","key":"b9","series-title":"Cancer Med","first-page":"13","article-title":"Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma","volume":"8","author":"Zhu H","year":"2019","unstructured":"Zhu H, Bi WL, Aizer A,  Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med. 2019;8(1):13\u201320."},{"key":"b10","series-title":"World Neurosurg","first-page":"565","article-title":"Recurrent atypical meningiomas: combining surgery and radiosurgery in one effective multimodal treatment","volume":"87","author":"Talacchi A","year":"2016","unstructured":"Talacchi A, Muggiolu F, De Carlo A, Nicolato A, Locatelli F, Meglio M. Recurrent atypical meningiomas: combining surgery and radiosurgery in one effective multimodal treatment. World Neurosurg. 2016;87:565\u2013572."},{"issue":"2","key":"b11","series-title":"J Neurooncol","first-page":"425","article-title":"Salvage therapy outcomes for atypical meningioma","volume":"138","author":"Chen WC","year":"2018","unstructured":"Chen WC, Hara J, Magill ST,  Salvage therapy outcomes for atypical meningioma. J Neurooncol. 2018;138(2):425\u2013433."},{"issue":"4","key":"b12","series-title":"World Neurosurg","first-page":"1014","article-title":"Treatment response and prognosis after recurrence of atypical meningiomas","volume":"84","author":"Cao X","year":"2015","unstructured":"Cao X, Hao S, Wu Z,  Treatment response and prognosis after recurrence of atypical meningiomas. World Neurosurg. 2015;84(4):1014\u20131019."},{"issue":"3","key":"b13","series-title":"Neurosurgery","first-page":"495","article-title":"De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome","volume":"61","author":"Krayenb\u00fchl N","year":"2007","unstructured":"Krayenb\u00fchl N, Pravdenkova S, Al-Mefty O. De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery. 2007;61(3):495\u2013504."},{"issue":"4","key":"b14","series-title":"J Neurosurg","first-page":"1179","article-title":"Surgical outcomes after reoperation for recurrent non\u2013skull base meningiomas","volume":"131","author":"Magill ST","year":"2019","unstructured":"Magill ST, Dalle Ore CL, Diaz MA,  Surgical outcomes after reoperation for recurrent non\u2013skull base meningiomas. J Neurosurg. 2019;131(4):1179\u20131187."},{"issue":"3","key":"b15","series-title":"Brain Pathol","first-page":"255","article-title":"The new WHO classification of brain tumours","volume":"3","author":"Kleihues P","year":"1993","unstructured":"Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3(3):255\u2013268."},{"issue":"2","key":"b16","series-title":"Acta Neuropathol","first-page":"97","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis DN","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD,  The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109."},{"issue":"6","key":"b17","series-title":"Acta Neuropathol","first-page":"803","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis DN","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G,  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803\u2013820."},{"issue":"4","key":"b18","series-title":"Neurosurgery","first-page":"753","article-title":"Glioma extent of resection and its impact on patient outcome","volume":"62","author":"Sanai N","year":"2008","unstructured":"Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753\u2013764.264-266."},{"issue":"1","key":"b19","series-title":"J Neurol Neurosurg Psychiatry","first-page":"22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson D","year":"1957","unstructured":"Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22\u201339."},{"issue":"5","key":"b20","series-title":"Lancet Oncol","first-page":"682","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm F","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D,  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682\u2013694."},{"key":"b21","series-title":"NPJ Genom Med","first-page":"15","article-title":"Genomic landscape of high-grade meningiomas","volume":"2","author":"Bi WL","year":"2017","unstructured":"Bi WL, Greenwald NF, Abedalthagafi M,  Genomic landscape of high-grade meningiomas. NPJ Genom Med. 2017;2:15."},{"issue":"8","key":"b22","series-title":"Neuro Oncol","first-page":"1113","article-title":"De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors","volume":"20","author":"Peyre M","year":"2018","unstructured":"Peyre M, Gauchotte G, Giry M,  De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors. Neuro Oncol. 2018;20(8):1113\u20131121."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/139\/3\/article-p769.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/139\/3\/article-p769.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/139\/3\/article-p769.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T10:52:28Z","timestamp":1716029548000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/139\/3\/article-p769.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":22,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2022.12.jns221815","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}